Evidence map›Paper›PMID 24997605›Full record

ArticleNature chemical biology2014

Extended ubiquitin species are protein-based DUB inhibitors.

Daria Krutauz, Noa Reis, Mark A Nakasone, Peter Siman, Daoning Zhang, Donald S Kirkpatrick, Steven P Gygi, Ashraf Brik, David Fushman, Michael H Glickman

Open access · greenAbstract read
In one paragraph

Article in Nature chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Molecular mechanisms underlying p62-dependent secretion of the Alzheimer-associated ubiquitin variant UBBProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Strategies for Monitoring "Ubiquitin C-Terminal Hydrolase 1" (Yuh1) Activity.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  5. Review
  6. Article
  7. Review
  8. The Dose-Dependent Pleiotropic Effects of the UBBFrontiers in molecular biosciences · 2021
    Review
  9. Recent Insights on Alzheimer's Disease Originating from Yeast Models.International journal of molecular sciences · 2018
    Review
  10. Different Expression Levels of Human Mutant Ubiquitin BFrontiers in molecular neuroscience · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Spermidine protects against α-synuclein neurotoxicity.Cell cycle (Georgetown, Tex.) · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Daria KrutauzDepartment of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Noa ReisDepartment of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Mark A Nakasone1] Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel. [2] Department of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland, College Park, Maryland, USA.
Peter SimanDepartment of Chemistry, Ben Gurion University of the Negev, Beer Sheva, Israel.
Daoning ZhangDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland, College Park, Maryland, USA.
Donald S KirkpatrickDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Steven P GygiDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Ashraf BrikDepartment of Chemistry, Ben Gurion University of the Negev, Beer Sheva, Israel.
David FushmanDepartment of Chemistry and Biochemistry, Center for Biomolecular Structure and Organization, University of Maryland, College Park, Maryland, USA.
Michael H GlickmanDepartment of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
Technion – Israel Institute of Technology · ILBen-Gurion University of the Negev · ILHarvard University · USUniversity of Maryland, College Park · US

Funding

Recognition of non-ubiquitin signals at the proteasomeR01GM095755 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI FUSHMAN, DAVID · 2011 to 2014
$1.4M
NIGMS NIH HHS GM095755NIGMS NIH HHS R01 GM095755
6 · The paper itself

Abstract

A frameshift mutation in the transcript of the ubiquitin-B gene leads to a C-terminally extended ubiquitin (Ub), UBB(+1). UBB(+1) has been considered to inhibit proteasomes and as such to be the underlying cause for toxic protein buildup correlated with certain neuropathological conditions. We demonstrate that expression of extended Ub variants leads to accumulation of heterogeneously linked polyubiquitin conjugates, indicating a pervasive effect on Ub-dependent turnover. 20S proteasomes selectively proteolyzed Ub extensions, yet no evidence for inhibition of 26S holoenzymes was found. However, among susceptible targets for inhibition was Ubp6, the primary enzyme responsible for disassembly of Lys48 linkages at 26S proteasomes. Processing of Lys48 and Lys63 linkages by other deubiquitinating enzymes (DUBs) was also inhibited. Disruption of Ub-dependent degradation by extended Ub variants may therefore be attributed to their inhibitory effect on select DUBs, thus shifting research efforts related to protein accumulation in neurodegenerative processes from proteasomes to DUBs.

Indexed as

Amino Acid SequenceEndopeptidasesLeupeptinsMolecular Sequence DataPolyubiquitinProteasome Endopeptidase ComplexProteasome InhibitorsSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsUbiquitinUbiquitinationATP dependent 26S proteasebenzyloxycarbonylleucyl-leucyl-leucine aldehydeEndopeptidasesLeupeptinsPolyubiquitinProteasome Endopeptidase ComplexProteasome InhibitorsSaccharomyces cerevisiae ProteinsUBB protein, humanUbiquitinUBP6 protein, S cerevisiae

Identifiers

PMID24997605
PMCPMC4466224
OpenAlexW1996213026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.